Skip to content

Ageing and longevity

Does anything actually slow ageing?

The hardest question on the site to answer honestly. A real study of living longer would take decades in people, and nobody has run one. What exists is work on blood tests and other body markers, and this page says so.

170 compounds studied for this · 55 with a completed trial of a hundred people or more · 36 with no study in people at all

What has actually been measured here

This page lists the compounds studied for ageing and longevity. These pages work the other way round. They take one goal at a time and list every compound by how many people it was measured in, most first. Each shows what the study found, and the trials that found nothing are counted.

Or open all 4 of these together in the finder.

Strong and Moderate 55

At least one finished trial that gave the compound to a hundred people or more. That tells you how much has been measured. It does not tell you whether it will work for you. The math sits under every band.

Metformin

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 489 people given it.6 reported
7 cited

A cheap, very safe diabetes drug that many people take hoping to live longer. Big studies in people have not shown it he...

Small moleculeLongevity

Epitalon

Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 266 people given it.6 reported
6 cited

A lab-made peptide based on a pineal gland extract. It has more human data than its reputation suggests, including 266 o...

PeptideAnti-aging

Taurine

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 120 people given it.5 reported
3 cited

A 2023 paper said falling taurine drives ageing. Two 2025 papers in people, one from the US government's own ageing inst...

SupplementLongevity

Spermidine

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 130 people given it.4 reported
4 cited

A natural compound in foods like wheat germ and aged cheese that helps cells clean house. A year-long memory study found...

SupplementLongevity

BPTES

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 513 people given it.1 reported
2 cited

The lab tool behind a separate clean-up idea. Worn-out cells use glutamine, a common amino acid, to cancel out their own...

Small moleculeLongevity

Telaglenastat

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 513 people given it.1 reported
5 cited

The only drug of its kind with proper studies in people, and those studies are in cancer. In the main one, 444 people wi...

Small moleculeLongevity

Navitoclax

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 137 people given it.2 reported
4 cited

The most-quoted drug for clearing worn-out cells in mice, and the one you cannot give to healthy people. In its first st...

Small moleculeLongevity

UBX0101

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 183 people given it.3 reported
4 cited

The first clean-up drug for worn-out cells tested in a proper study against a real symptom. In 183 people with knee arth...

Small moleculeLongevity

Cardiac glycosides

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 6,800 people given it.
2 cited

Two 2019 papers said these heart drugs kill worn-out cells in a dish and in mice. Separately, digoxin was tested for hea...

Small moleculeLongevity

Green tea extract

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 1,075 people given it.4 reported
2 cited

In people, the biggest study gave 1,075 women 843 mg of EGCG a day for a year. Liver blood tests went up in 6.7 percent...

SupplementLongevity

Therapeutic Plasma Exchange

Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 389 people given it.6 reported
7 cited

A standard hospital procedure that takes out plasma and puts a blood protein called albumin back. A 347-person trial in...

ProcedureLongevity

Enalapril

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 2,822 people given it.5 reported
3 cited

In people, it is a blood pressure and heart failure drug with one of the deepest records in heart medicine for keeping s...

Small moleculeLongevity

Azithromycin and roxithromycin

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 480 people given it.
2 cited

Two approved antibiotics that cleared about 97 percent of worn-out 'zombie' human cells in one lab test, while their clo...

Small moleculeAnti-aging

Thymalin with epitalon

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 1,106 people given it.7 reported
2 cited

A pairing that was actually studied as a pair. 266 older people were followed for six to eight years on thymalin and epi...

BlendLongevity

GDF15

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 313 people given it.3 reported
6 cited

GDF15 is a stress signal your body makes when cells are in trouble. It acts on the part of the brain that makes you feel...

BiologicMetabolic

Mitoglitazone

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 385 people given it.1 reported
4 cited

In people, it was tested in 356 people with type 2 diabetes and 29 people with Alzheimer disease. The company ran both s...

Small moleculeLongevity

PQQ

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 116 people given it.5 reported
4 cited

Sold to grow new mitochondria, the cell's power plants. In a six-week training study, PQQ raised one mitochondria-buildi...

SupplementAntioxidant

Risuteganib

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 263 people given it.
4 cited

A peptide injected into the eye for dry macular degeneration and for retina swelling caused by diabetes. About 435 peopl...

PeptideHealing & Recovery

Thymalin

Moderate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 308 people given it.7 reported
4 cited

A peptide extract from calf thymus, used in the Soviet Union and Russia since the 1980s. There is a large Russian medica...

PeptideImmune

Resveratrol

Moderate. At least one finished study in people, and at least 100 people who took it. 14 completed trials, 403 people given it.7 reported
14 cited

Resveratrol is the grape and red wine compound behind the first big wave of anti-ageing research. It is one of the most...

SupplementLongevity

Empagliflozin

Strong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 16,738 people given it.4 reported
4 cited

A diabetes pill that also protects the heart and kidneys. Four big studies in more than 23,000 sick people found fewer d...

Small moleculeMetabolic

Elamipretide

Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 487 people given it.6 reported
5 cited

Approved in 2025 for one rare genetic disease, Barth syndrome, on a result its own main study missed. In a large final-s...

PeptideAnti-aging

Idebenone

Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 732 people given it.
5 cited

Approved in the European Union for one rare inherited eye disease that causes sudden vision loss. The approval came unde...

SupplementAntioxidant

Zoledronic acid

Strong. At least two finished studies in people, and at least 1,000 people who took it. 4 completed trials, 7,176 people given it.
4 cited

An approved once-a-year bone drip with an odd, unexplained link to fewer deaths. In a study of people after a broken hip...

Small moleculeLongevity

CoQ10

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 162 people given it.4 reported
3 cited

One strong study in people with serious heart failure cut major heart problems from 26% to 15%. For statin muscle pain,...

SupplementAntioxidant

Everolimus

Strong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 1,024 people given it.
3 cited

The rapamycin copy behind the first believable human result in ageing research. In older adults, it improved the immune...

Small moleculeLongevity

RTB101

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 1,024 people given it.3 reported
3 cited

The most important failed trial in ageing research. It looked good in two mid-stage trials, then did nothing in a 1,024...

Small moleculeLongevity

Carnosine

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 299 people given it.4 reported
2 cited

A two-part molecule the body makes itself, sold as an anti-ageing supplement. It is not approved anywhere for anything....

SupplementAntioxidant

Ruxolitinib

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 309 people given it.
2 cited

An approved drug that blocks two signalling enzymes, JAK1 and JAK2. In old mice it quieted the inflammatory signals from...

Small moleculeAnti-aging

Simvastatin

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 24,980 people given it.6 reported
2 cited

Mixed into mouse food at two doses from 9 months of age, simvastatin did not change how long mice lived, in males or fem...

Small moleculeLongevity

Tesamorelin

Strong. At least two finished studies in people, and at least 1,000 people who took it. 8 completed trials, 1,729 people given it.10 reported
8 cited

An FDA-approved shot that shrinks belly fat, the deep fat around the organs. It is also being studied for memory and thi...

PeptideGrowth Hormone

Argireline

Moderate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 155 people given it.7 reported
7 cited

A skin cream peptide sold as a 'Botox-like' wrinkle softener for lines from facial expressions.

PeptideCosmetic

BNP and nesiritide

Strong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 7,149 people given it.4 reported
6 cited

BNP is a heart hormone with two lives. As a blood test, it is the standard way to check for heart failure. As a drug, it...

PeptideHormone

Creatine

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 168 people given it.5 reported
4 cited

One of the most studied supplements there is. It clearly boosts strength. Its effect on muscle size is smaller than the...

SupplementMuscle & Performance

FGF21

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 350 people given it.4 reported
4 cited

FGF21 is a hormone your liver makes when you fast, eat sugar or eat less protein. Lab-built versions healed liver scarri...

BiologicMetabolic

EGCG

Strong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 1,172 people given it.5 reported
3 cited

A mid-stage study of 800 mg of EGCG a day in multiple sclerosis was stopped by its safety board. 5 of the 7 people on th...

SupplementAntioxidant

Methotrexate

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 5,022 people given it.4 reported
2 cited

The best test we have of whether calming long-term inflammation makes you live longer. In a big heart trial in people, i...

Small moleculeImmune

Mifepristone

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 320 people given it.4 reported
2 cited

In people, mifepristone is approved for high blood sugar in Cushing's syndrome and for ending early pregnancy. Nobody ha...

Small moleculeHormone

Nicotinamide

Moderate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 591 people given it.2 reported
4 cited

A plain form of vitamin B3. In a large final-stage study of 386 people at high risk, 500 mg twice a day cut new skin can...

SupplementLongevity

Oxaloacetate

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 112 people given it.4 reported
2 cited

Fed to mice from 4 months of age, it did not change how long they lived, in either sex. The human record is two small st...

SupplementLongevity

Sodium phenylbutyrate

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 148 people given it.4 reported
2 cited

In people, it is approved for a rare disease of ammonia build-up. A pill that paired it with a bile acid was approved fo...

Small moleculeLongevity

Sermorelin

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 139 people given it.8 reported
3 cited

A piece of the hormone that tells your body to make growth hormone. It was once approved for children short on growth ho...

PeptideGrowth Hormone

Nattokinase

Strong. At least two finished studies in people, and at least 1,000 people who took it. 9 completed trials, 1,795 people given it.6 reported
13 cited

Nattokinase is a clot-busting enzyme made when bacteria ferment soybeans into natto, a Japanese food. For a supplement,...

BiologicLongevity

Sulforaphane

Moderate. At least one finished study in people, and at least 100 people who took it. 7 completed trials, 423 people given it.6 reported
7 cited

Three studies set a main goal in advance, and all three missed it. They tested a prostate cancer blood marker (PSA) in 7...

SupplementAntioxidant

Niacin

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 29,087 people given it.7 reported
5 cited

The only NAD-pathway product ever tested against real heart outcomes, in 25,673 people in HPS2-THRIVE and 3,414 in AIM-H...

SupplementLongevity

Omega-3

Strong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 34,050 people given it.4 reported
5 cited

Two big heart studies of fish oil drugs came to opposite answers, and the dummy pill may be why. People with more omega-...

SupplementLongevity

Vitamin D

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 25,871 people given it.4 reported
5 cited

The most-tested supplement there is, and the big tests mostly came back empty. In a study of 25,871 adults, a daily vita...

SupplementLongevity

Low-dose lithium

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 106 people given it.5 reported
4 cited

The tap water studies people quote are not tests on people. A review pooled 15 studies that compared lithium in local wa...

SupplementLongevity

MIB-626

Moderate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 107 people given it.1 reported
4 cited

The only NMN product with a real set of studies in people: three studies with a dummy pill group, about 104 people in al...

SupplementLongevity

Curcumin

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 195 people given it.5 reported
3 cited

Across 103 studies and 42 health measures, only four had high-certainty evidence, including CRP, a blood marker of swell...

SupplementAntioxidant

Hydralazine

Strong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 1,724 people given it.4 reported
3 cited

An old blood pressure drug. In people, paired with a nitrate, it cut deaths in heart failure. It made worms live longer...

Small moleculeLongevity

NRPT

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 176 people given it.3 reported
3 cited

In 120 healthy adults aged 60 to 80, it raised NAD in whole blood by about 40 percent at the normal dose and about 90 pe...

SupplementLongevity

Minocycline

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 966 people given it.
2 cited

It did not change how long mice lived, in males or females, when started late in life. In 412 people with ALS (Lou Gehri...

Small moleculeLongevity

Trametinib

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 1,192 people given it.
2 cited

An approved melanoma drug that made mice live longer. Added to rapamycin, the effects stacked, which suggests the two dr...

Small moleculeLongevity

Selenium

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 35,533 people given it.1 reported
1 cited

SELECT, a trial of 35,533 men, tested selenium, vitamin E, both, or a dummy pill. Selenium did not prevent prostate canc...

SupplementLongevity

Limited and Preliminary 79

Someone has been given it and a result was published, but in fewer than a hundred people. Or the studies in people only watched and never gave anybody anything. The math on each card says exactly how thin.

Rapamycin

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 25 people given it.8 reported
3 cited

An approved drug that blocks mTOR, a growth switch in cells. It makes many kinds of animals live longer. Some people tak...

Small moleculeLongevity

NAD+

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.7 reported
1 cited

A helper molecule every cell needs to make energy. It is sold as drips and shots for anti-aging and recovery. Levels fal...

SupplementLongevity

NMN

Limited. People have taken it in a published study, but fewer than 100 of them. 4 completed trials, 94 people given it.6 reported
4 cited

A pill the body turns into NAD+. It is studied for blood sugar and strength in ageing. Early studies in people show smal...

SupplementLongevity

MOTS-c

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it.6 reported
8 cited

A tiny peptide made from the DNA in the cell's power plants. In people there are real studies: a gene variant common in...

PeptideLongevity

Ginsenoside Rg3

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 24 people given it.
2 cited

A compound from ginseng that pushes worn-out cells in opposite directions depending on the cell. In a dish it brought wo...

SupplementLongevity

17-DMAG

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 49 people given it.3 reported
4 cited

In people, it was only ever given into a vein to about 80 people with advanced cancer, in early dose-finding studies. He...

Small moleculeLongevity

MitoQ

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.7 reported
1 cited

A widely sold antioxidant aimed at mitochondria. In a study of 20 healthy older adults, it helped their blood vessels wo...

SupplementAntioxidant

Nicotinamide Riboside

Limited. People have taken it in a published study, but fewer than 100 of them. 4 completed trials, 90 people given it.5 reported
5 cited

A form of vitamin B3 that reliably raises NAD in people. That part is proven. A big mouse program found it did not help...

SupplementLongevity

DT2216

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 20 people given it.3 reported
4 cited

Built to fix navitoclax's platelet problem. It hands the target protein to a cell tool that platelets barely have. In it...

Small moleculeLongevity

ABT-737

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.1 reported
2 cited

The lab parent of navitoclax, used in mice to clear worn-out cells. Nobody has ever been given ABT-737 in a published st...

Small moleculeLongevity

Gpld1

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.4 reported
2 cited

A liver enzyme released into the blood during exercise. In mice, it passed the brain benefits of running to old mice tha...

BiologicLongevity

GlyNAC

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.3 reported
2 cited

A mix of glycine and NAC, two building blocks the body uses to make its main antioxidant, glutathione. Small studies in...

SupplementAntioxidant

CCL11 Blockade

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.5 reported
2 cited

A signalling protein that rises with age in human blood and harms new brain cell growth in mice. There is data in people...

BiologicLongevity

Lamivudine

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.3 reported
2 cited

A thirty year old HIV and hepatitis B pill. Some scientists think old gene fragments waking up in our DNA drive the cons...

Small moleculeAnti-aging

Beta-2 Microglobulin

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.5 reported
1 cited

A blood protein that rises with age. Injected into young mice, it harms new brain cell growth and memory. In people it i...

BiologicLongevity

OSK Partial Reprogramming

Preliminary. Studied in people, but no published study has had people take it. 1 registered with no result.5 reported
1 cited

Three of the four Yamanaka genes, switched on briefly to reset the ageing marks on DNA without wiping out what kind of c...

BiologicLongevity

RTR242

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.1 reported
1 cited

The first drug in people from Retro Biosciences, the longevity company backed by Sam Altman. It is a pill meant to resto...

Small moleculeNootropic & CNS

Methylene Blue

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 26 people given it.7 reported
3 cited

Methylene blue is an FDA-approved antidote for a rare blood problem called methemoglobinemia. Biohackers take small dose...

Small moleculeAntioxidant

25-Hydroxycholesterol

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.2 reported
1 cited

A cholesterol byproduct your body makes itself. A 2025 study found it made old mice's main artery less stiff, about as m...

Small moleculeLongevity

FOXO4-DRI

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 74 people given it.8 reported
1 cited

An experimental peptide that kills worn-out cells in animal studies. It has not been tested in people.

PeptideAnti-aging

Apelin

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 68 people given it.3 reported
6 cited

Apelin is a natural signal that widens arteries and makes the heart pump harder. That was shown with short drips in abou...

PeptideMetabolic

Epicatechin

Limited. People have taken it in a published study, but fewer than 100 of them. 4 completed trials, 44 people given it.1 reported
6 cited

In people, small studies of the pure compound found a small drop in fasting insulin at 100 mg a day and nothing at 25 mg...

SupplementLongevity

Dasatinib

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 74 people given it.3 reported
4 cited

An approved leukemia drug also tried, with quercetin, to clear worn-out cells. Early studies with no comparison group lo...

Small moleculeLongevity

Quercetin

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 60 people given it.2 reported
4 cited

A plant compound in many foods, used with the drug dasatinib to clear worn-out cells. The pair does clear those cells in...

SupplementLongevity

(R/S)-1,3-Butanediol

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.2 reported
3 cited

In people, it raises blood ketones for a few hours. In 9 cyclists, it gave 5 of them moderate to severe gut problems and...

SupplementLongevity

Clusterin

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it, 1 registered with no result.4 reported
3 cited

A blood protein that goes up with exercise. In old mice and in mice with an Alzheimer-like illness, it calmed brain infl...

BiologicLongevity

Urolithin A

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.4 reported
3 cited

A compound your gut makes from pomegranates and berries. In older adults it helped muscle stamina and strength on some t...

SupplementMuscle & Performance

Young Plasma Infusion

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 18 people given it.6 reported
3 cited

Plasma from donors aged 18 to 30, dripped into older people. The one proper trial took 18 people with Alzheimer disease...

ProcedureLongevity

Alpha-2-Macroglobulin

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 75 people given it.6 reported
2 cited

A blood protein that blocks a wide range of enzymes, sold as a knee injection. The one proper trial in 75 people found i...

BiologicLongevity

Klotho

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.
2 cited

Nobody has given klotho to a person in a published study. People with higher blood levels tend to live longer and think...

BiologicLongevity

Metformin plus rapamycin

Preliminary. Studied in people, but no published study has had people take it. 2 registered with no result.2 reported
2 cited

Nobody has tested this pair in people. In mice fed both from 9 months, typical lifespan rose 23 percent in both sexes. B...

Small moleculeLongevity

Plasma Dilution

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 42 people given it.6 reported
2 cited

The mouse experiment that asked whether young blood is needed at all. Swapping half the plasma for salt water plus album...

ProcedureLongevity

Ergothioneine

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.1 reported
1 cited

An antioxidant from food, mainly mushrooms, that your body pulls into its cells. It is studied as a possible longevity n...

SupplementAntioxidant

FGF17

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.4 reported
1 cited

The factor found when young spinal fluid was pumped into the brains of old mice. In people it is known for something els...

BiologicLongevity

Fisetin

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.3 reported
1 cited

A plant compound found in strawberries, sold to clear worn-out cells. No results in people yet. One mouse study found lo...

SupplementLongevity

TIMP2

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.4 reported
1 cited

A protein found in high amounts in human umbilical cord blood. In old mice, it restored how the memory centre of the bra...

BiologicLongevity

SkQ1

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.4 reported
1 cited

SkQ1 is an antioxidant aimed at mitochondria, the cell's power plants. In Russia it is registered as an eye drop for dry...

Small moleculeAntioxidant

NAD+ with glutathione

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 21 people given it.5 reported
2 cited

Usually two separate drips or shots given in one clinic visit, not one vial, because no premixed product is standard. NA...

BlendLongevity

Rilmenidine

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.1 reported
1 cited

A European blood pressure pill that makes tiny worms live longer. In mice, the results are worse than nothing. It did wh...

Small moleculeLongevity

Humanin

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it.6 reported
5 cited

A tiny peptide made from mitochondrial DNA. In people it has been watched, not given. It falls with age, runs high in th...

PeptideLongevity

NAD+ / B Complex

Limited. People have taken it in a published study, but fewer than 100 of them. 5 completed trials, 34 people given it.8 reported
5 cited

Injectable NAD+ mixed with B12, and sometimes B6, sold as a clinic drip or as a vial for shots under the skin. No study...

BlendLongevity

Acarbose

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.4 reported
2 cited

An old, cheap diabetes pill that slows how fast starch turns into sugar. In people, a large heart study found no heart b...

Small moleculeLongevity

Glutathione

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 54 people given it.8 reported
2 cited

The body's main antioxidant inside cells, made of three amino acids. People take it for skin, for the liver and to clean...

SupplementAntioxidant

Calcium AKG

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.3 reported
1 cited

A supplement made from a natural body chemical, taken for healthy ageing. One mouse study found longer life. The US gove...

SupplementLongevity

Dimethyl fumarate

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 54 people given it.4 reported
3 cited

An approved multiple sclerosis drug, and the cleanest drug we have for switching on NRF2. In mice, it did not extend lif...

Small moleculeAntioxidant

Alpha-ketobutyrate

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.3 reported
2 cited

One lifespan paper, in tiny worms. In people, a closely related body chemical, alpha-hydroxybutyrate, is not a sign of l...

SupplementLongevity

BGE-102

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.2 reported
2 cited

BioAge's daily pill that blocks NLRP3, a trigger of long-term inflammation. In an early study, a blood marker of inflamm...

Small moleculeLongevity

SHLP2

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.6 reported
2 cited

A tiny peptide made by mitochondria, the power plants inside your cells. It has a known receptor, a weight result in mic...

PeptideLongevity

GDF11

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.3 reported
1 cited

GDF11 is the protein behind the young blood story. Two famous mouse papers in 2013 and 2014 said it drops with age and t...

BiologicAnti-aging

Mitochondrial+ blend

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.6 reported
1 cited

A 55 mg vial of three peptides, sold at 9 mg SS-31, 16 mg TB-500 and 30 mg MOTS-c. MOTS-c is more than half the powder,...

BlendLongevity

MOTS-c with SS-31

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.6 reported
1 cited

Two peptides aimed at mitochondria, the energy makers inside cells, sold as one stack. SS-31 is elamipretide. It reached...

BlendLongevity

Ursodeoxycholic acid

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it.3 reported
1 cited

An approved bile acid that also protects mitochondria. In people, a small safety study in Parkinson disease is the resul...

Small moleculeLongevity

Danazol

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 63 people given it.5 reported
5 cited

The one drug here that made telomeres longer in people. Telomeres are the caps on the ends of your DNA that shorten with...

HormoneHormone

Nomlabofusp

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 28 people given it.
5 cited

A replacement for frataxin, the protein people with Friedreich ataxia are missing. It is joined to a short peptide that...

BiologicNootropic & CNS

Halofuginone

Preliminary. Studied in people, but no published study has had people take it. 3 human studies where nobody was given it, 1 registered with no result.2 reported
4 cited

It has barely been tested in people. 24 cancer patients took it by mouth in an early safety study, and nausea capped the...

Small moleculeLongevity

Irisin

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 7 people given it.2 reported
4 cited

Irisin is a small protein your muscles release, and people link it to exercise. Nobody has ever given it to a person. In...

BiologicMetabolic

Adiponectin

Preliminary. Studied in people, but no published study has had people take it. 3 human studies where nobody was given it.2 reported
3 cited

Adiponectin is a hormone your fat makes, and it falls as you gain fat. Many studies link low levels to diabetes. It has...

BiologicMetabolic

NAC

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 15 people given it.
3 cited

NAC is what the body uses to make glutathione. It is FDA-approved to thin mucus and as the standard antidote for a Tylen...

SupplementAntioxidant

Neuropeptide Y

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 20 people given it.5 reported
3 cited

The one big test in people was a year-long study of a pill that blocks one of its receptors, in 1,661 overweight and obe...

PeptideNootropic & CNS

Pinealon

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.6 reported
3 cited

A tiny lab-made peptide from Khavinson's group, studied for brain protection and thinking.

PeptideNootropic & CNS

Alpha-Lipoic Acid

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.3 reported
2 cited

An antioxidant studied for nerve pain in diabetes and for metabolic health. It is sold as a supplement and used as a dru...

SupplementAntioxidant

Follistatin

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 12 people given it.
2 cited

A natural protein that blocks myostatin and activin, two brakes on muscle growth. It is studied mostly as gene therapy f...

BiologicMuscle & Performance

RLS-1496

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it, 1 registered with no result.1 reported
2 cited

Rubedo's skin cream meant to clear worn-out skin cells. In an early study in psoriasis, eczema and sun-damaged skin, it...

Small moleculeAnti-aging

Adropin

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.
1 cited

A peptide whose blood level is lower in people who are heavier and older. Every human study just measures it. No one has...

PeptideMetabolic

ATX-304

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.2 reported
1 cited

ATX-304 is a pill that switches on AMPK, the cell's fuel sensor. It has one 28-day pilot study in people with type 2 dia...

Small moleculeMetabolic

Pterostilbene

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 80 people given it.4 reported
2 cited

One study in people: 80 adults with high cholesterol. At 250 mg a day, it lowered the top blood pressure number by 7.8 p...

SupplementLongevity

DSIP with selank and epitalon

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 62 people given it.6 reported
3 cited

A sleep and body clock blend, usually 2 mg DSIP, 2 mg epitalon and 0.5 mg selank. So the two bigger ingredients are each...

BlendNootropic & CNS

TUDCA

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 54 people given it.7 reported
5 cited

In twenty obese adults over four weeks, insulin sensitivity in the liver and muscle rose about 30 percent on a detailed...

SupplementLongevity

Ambroxol

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 73 people given it.1 reported
3 cited

A cough medicine sold over the counter in much of the world. At high doses it raises a key enzyme in the brain. The one...

Small moleculeAnti-aging

Endoluten

Preliminary. Studied in people, but no published study has had people take it. 3 human studies where nobody was given it.8 reported
3 cited

A pineal gland capsule sold on the long-life claims of two other products. A PubMed search for Endoluten finds zero pape...

PeptideAnti-aging

Ashwagandha

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.2 reported
2 cited

An optional part of Aaron's stack, for stress and sleep. There are trials of root extracts tested against a dummy pill....

SupplementLongevity

ER-100

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.1 reported
2 cited

The first test in people of partial cell reprogramming. Life Biosciences gave the first patient ER-100 in June 2026. It...

BiologicLongevity

Foselutoclax

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.2 reported
2 cited

An eye shot that clears worn-out cells. In people with diabetic swelling in the eye, it kept up with the standard drug a...

Small moleculeLongevity

Vitamin K2

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.1 reported
2 cited

The K2 half of Aaron's vitamin D3 plus K2 pairing. In the Rotterdam Study, people who ate more K2 in their food had less...

SupplementLongevity

Apigenin

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.1 reported
1 cited

Sold as a way to protect your NAD by blocking CD38, an enzyme that uses NAD up. That rests on one 2013 paper in cells an...

SupplementAntioxidant

Magnesium

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 46 people given it.4 reported
1 cited

It lowers blood pressure by a real but small amount, about 2 points. The sleep evidence is three small studies in 151 pe...

SupplementLongevity

NMNH

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.1 reported
1 cited

Raises NAD in cells and mouse tissue faster and higher than NMN, by a route that skips two slow enzyme steps. In the sam...

SupplementLongevity

NRH

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 65 people given it.1 reported
1 cited

In cells grown in a dish, NRH raised NAD 2.5 to 10-fold within an hour, more than NR or NMN at the same amount. It also...

SupplementLongevity

SRT2104

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.
1 cited

The sirtuin drug that actually reached human trials against a dummy pill. It was built to succeed where resveratrol was...

Small moleculeLongevity

Animal or lab only, and nothing measured 36

Studied in animals or in cells in a dish, or studied in people for something else entirely. Listed, not hidden, because knowing a thing has not been tested in a person is the useful part.

Piperlongumine

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 3 lab studies, no human study.2 reported
none cited

A compound from long pepper. A 2016 lab test found it kills worn-out human skin cells in a dish. Everything published on...

Small moleculeLongevity

Chemical Reprogramming Cocktails

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 3 lab studies, no human study.4 reported
none cited

Mixes of small molecules that do the job of the gene therapy in reprogramming. All the ageing work is in cells in a dish...

Small moleculeLongevity

Caffeic acid phenethyl ester

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 4 animal studies, 2 lab studies, no human study.1 reported
none cited

Nobody has published a study of CAPE itself in people. In mice, it did not extend lifespan at either dose by the NIA pro...

SupplementLongevity

OSKM Cyclic Partial Reprogramming

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 6 animal studies, no human study.5 reported
none cited

All four Yamanaka genes, switched on in short bursts. It made a mouse bred to age too fast live longer, not a normal mou...

BiologicLongevity

Procyanidin C1

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.2 reported
none cited

A grape seed compound that a 2021 paper said kills worn-out cells and helps old mice live longer. Since March 2026 the j...

SupplementLongevity

Vilon

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 1 lab study, no human study.6 reported
none cited

A tiny lab-made peptide from Khavinson's group, studied for the immune system and ageing.

PeptideAnti-aging

Astaxanthin

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.5 reported
none cited

It made male mice live longer once. When the same program tested it again at a different dose, it did nothing. In female...

SupplementAntioxidant

Protandim

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, no human study.5 reported
none cited

A supplement brand that really did make male mice live longer in the US government testing program. Almost no supplement...

SupplementAntioxidant

Cardiogen

None. No study cited on this page yet. no study cited on this page yet.2 reported
none cited

A lab-made peptide from Russian research, aimed at the heart and blood vessels as they age.

PeptideAnti-aging

E5 Plasma Fraction

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 4 animal studies, no human study.4 reported
none cited

A cleaned-up part of the blood plasma of young pigs, given to old rats. It more than halved the tissue age of their bloo...

ProcedureLongevity

Platelet Factor 4

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 3 animal studies, no human study.4 reported
none cited

A protein released by the tiny cells that help blood clot. In 2023, three separate labs reported it restored memory in o...

BiologicLongevity

Rapamycin plus acarbose

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 7 animal studies, no human study.5 reported
none cited

No person has taken these two together in any study. In mice started at 9 months, typical lifespan rose 28 percent in fe...

Small moleculeLongevity

Anti-IL-11

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, no human study.2 reported
none cited

Blocking a single swelling signal made mice live longer and healthier. It worked even when started in mice that were alr...

BiologicLongevity

Senolytic CAR T cells

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 3 animal studies, no human study.
none cited

Living immune cells, called T cells, engineered to find and kill worn-out 'zombie' cells by a marker on their surface ca...

BiologicImmune

Thymulin

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, no human study.1 reported
none cited

A thymus hormone that needs zinc to work. It is studied for immune ageing, swelling and pain, mostly in the lab and in a...

PeptideImmune

17-alpha-estradiol

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 4 animal studies, no human study.4 reported
none cited

In male mice, it has made them live longer again and again, even at higher doses and even when started late in life. It...

HormoneLongevity

Cartalax

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 4 lab studies, no human study.8 reported
none cited

A tiny peptide, just three amino acids long, sold for joints. Almost all the research is on cells in a dish, done by the...

PeptideAnti-aging

Livagen

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 lab studies, no human study.4 reported
none cited

Livagen is a four building block peptide from Khavinson's institute, sold for liver and gut health. All the work so far...

PeptideLongevity

LOY-002

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.1 reported
none cited

A daily pill for older dogs that could become the first drug the FDA approves to extend lifespan. The FDA accepted its s...

Small moleculeLongevity

NDGA

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.4 reported
none cited

In male mice, it made them live longer at three different doses, and bigger doses did more. It never worked in females....

SupplementLongevity

o-Vanillin

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 3 lab studies, no human study.
none cited

A natural cousin of vanillin, the vanilla smell chemical. It cleared worn-out 'zombie' cells from human spinal disc tiss...

Small moleculeAnti-aging

Trigonelline

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, no human study.2 reported
none cited

Trigonelline is a natural compound in coffee and fenugreek that the body can turn into NAD+. It improved muscle function...

SupplementLongevity

5-amino-1MQ with SLU-PP-332

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.7 reported
none cited

A capsule mixing two research chemicals, usually 50 mg of 5-amino-1MQ with 0.25 mg of SLU-PP-332. That is 200 to 1 by we...

BlendMetabolic

CMS-121

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.2 reported
none cited

CMS-121 is a lab-made cousin of fisetin, from the Salk Institute. In mouse models of Alzheimer's it improved memory and...

Small moleculeNootropic & CNS

DNSP-11

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 4 animal studies, 1 lab study, no human study.2 reported
none cited

A peptide of 11 amino acids cut from the parent form of GDNF. GDNF is a growth factor that failed to help Parkinson dise...

PeptideNootropic & CNS

Senolytic vaccine (anti-GPNMB)

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 3 animal studies, no human study.
none cited

A vaccine that trains the immune system to attack GPNMB, a protein found in high amounts on worn-out 'zombie' cells. In...

BiologicImmune

SLU-PP-332

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.8 reported
none cited

An experimental compound sold as exercise in a pill. It boosts how muscle burns fuel in mice. It has never been tested i...

Small moleculeMuscle & Performance

SG1002

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, no human study.1 reported
none cited

No results in people for ageing. Hydrogen sulfide is needed for eating less to extend life in several species, so a pill...

Small moleculeLongevity

SS-20

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 4 animal studies, 1 lab study, no human study.6 reported
none cited

The sister of SS-31, the peptide that became the approved drug elamipretide. SS-20 cannot mop up free radicals, the unst...

PeptideAntioxidant

5-Amino-1MQ

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.6 reported
none cited

An experimental small molecule that blocks an enzyme linked to fat storage. It has only been studied in animals, and it...

Small moleculeMetabolic

BAM15

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 3 animal studies, no human study.2 reported
none cited

BAM15 makes cells burn fuel as heat. In mice it reversed obesity and poor blood sugar control, with a wider safety margi...

Small moleculeMetabolic

Melatonin

None. No study cited on this page yet. no study cited on this page yet.1 reported
none cited

A 2013 review that pooled studies found melatonin had a small effect on sleep problems. No blood test sets your dose. Wh...

SupplementLongevity

ISRIB

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 3 animal studies, 1 lab study, no human study.4 reported
none cited

ISRIB is not an approved medicine anywhere. No person has taken it in a registered study. In mice, it brought back lost...

Small moleculeAnti-aging

Meclizine

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.6 reported
none cited

A travel sickness pill you can buy without a prescription. It made male mice live longer in one round, then did nothing...

Small moleculeLongevity

Ovagen

Animal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 1 lab study, no human study.7 reported
none cited

Sold as a liver and gut peptide, with the sequence Glu-Asp-Leu. A PubMed search for Ovagen finds 34 papers, and none is...

PeptideAnti-aging

Zinc

None. No study cited on this page yet. no study cited on this page yet.1 reported
none cited

A mineral your body needs, with real evidence about shortage in people. High daily doses taken just in case are the prob...

SupplementLongevity

Reading on this goal

Dispatch 001: Five Retatrutide Phase 3 Trials Have Finished And None Has Posted Results

Five big retatrutide studies covering 6,415 people have finished collecting results, and none has shared them. A CagriSema against tirzepatide study finished in July at a low tirzepatide dose that suits the company paying for it. And a review that pooled 378 studies ranked what actually prevents diabetes.

Peptides for Longevity: What the Evidence Actually Shows in 2026

A full review of every peptide and related compound sold for aging: GLP-1 drugs, rapamycin, the growth hormone peptides, epitalon, thymalin, klotho, humanin, senolytics, SS-31, GHK-Cu, MOTS-c and FOXO4-DRI. What happened in people, what happened in animals and the legal status of each, in one table. Plain English.

Senolytics in 2026: Dasatinib plus Quercetin, Fisetin, and What Human Trials Have Shown

Every senolytic study in people that has reported as of September 2026: the fisetin studies (one failed, two still unfinished), foselutoclax in the eye, RLS-1496 on skin, and the small dasatinib plus quercetin tests in lung scarring and kidney disease. Plus why the capsules sold as senolytics have nothing to do with any of it. Plain English.

Peptides for Sleep: DSIP, Epitalon and Pinealon Against the Evidence

What the DSIP sleep studies from 1981 to 1992 actually found, why an FDA panel voted against DSIP (emideltide) and for Epitalon in July 2026, what one Russian lab's melatonin data can and cannot show, how growth hormone signals change deep sleep, and how it all compares with approved sleep drugs. Plain English.

Fasting worth reading alongside this

What the number counts, exactly

The number on each card is how many sources on that compound’s page are studies in people. It is counted the same simple way for all 453 compounds. You can check any of it by opening the profile and reading the list of sources. That is the whole point of showing a number at all.

It counts what we cite. It does not claim how much research exists. A compound with three studies in people here may have thirty in print, and the honest thing to say is that we have read and listed three. It is also not a quality score. Three small, loose studies count the same as three careful ones. So the groups tell you how much was measured in people, and the profile page tells you how well.

Other goals